{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:22:56Z","timestamp":1780514576888,"version":"3.54.1"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_almed-2025-0148_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Troponins are a complex of three proteins that play a key role in the contraction of striated muscles. Currently, cardiac troponins T (cTnT) and I (cTnI) are the best biomarkers for acute myocardial infarction (AMI) diagnostic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2025-0148_abs_002\">\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Immune-mediated toxicity due to Pembrolizumab was suspected in a 70-year-old male patient with gastric adenocarcinoma. To confirm this, creatine kinase (CK) and high sensitivity troponin T (hs-cTnT) analysis was carried out, giving values above the reference range. While CK normalized over time, hs-cTnT levels remained high. Before opting to perform an endomyocardial biopsy, high-sensitive troponin I (hs-cTnI) was measured, yielding a normal value. Due to discrepancies in troponin levels, a standard protocol was followed to confirm the presence of analytical interferences, that was negative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2025-0148_abs_003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The discrepancy observed between both troponin levels, and the absence of analytical interference, led us to exclude cardiac damage in our patient. So, the most probable cause of elevated cTnT was muscle involvement. This case highlights the importance of confirming troponin results using an alternative assay to rule out limited specificity and emphasizes the need for accessible tools to identify potential analytical interferences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/almed-2025-0148","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:57:22Z","timestamp":1763967442000},"page":"156-159","source":"Crossref","is-referenced-by-count":1,"title":["High sensitive troponin T elevation in an oncology patient on treatment with Pembrolizumab"],"prefix":"10.1515","volume":"7","author":[{"given":"Alberto","family":"Alcalde Morales","sequence":"first","affiliation":[{"name":"Laboratory Medicine Department , Hospital Universitario Virgen Macarena , Seville , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Reyes Milla","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Department , Hospital Universitario Virgen Macarena , Seville , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufino","family":"Mond\u00e9jar Garc\u00eda","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Department , Hospital Universitario Nuestra Se\u00f1ora de Valme , Seville , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Le\u00f3n Justel","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Department , Hospital Universitario Virgen Macarena, Instituto Biomedicina Sevilla IBIs\/CSIC\/Universidad de Sevilla\/Universidad Loyola Andalucia , Seville , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2026051310150656709_j_almed-2025-0148_ref_001","doi-asserted-by":"crossref","unstructured":"Katrukha, IA. Human cardiac troponin complex. Structure and functions. Biochem Mosc 2013;78:1447\u201365. https:\/\/doi.org\/10.1134\/s0006297913130063.","DOI":"10.1134\/S0006297913130063"},{"key":"2026051310150656709_j_almed-2025-0148_ref_002","doi-asserted-by":"crossref","unstructured":"Garg, P, Morris, P, Fazlanie, AL, Vijayan, S, Dancso, B, Dastidar, AG, et al.. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med 2017;12:147\u201355. https:\/\/doi.org\/10.1007\/s11739-017-1612-1.","DOI":"10.1007\/s11739-017-1612-1"},{"key":"2026051310150656709_j_almed-2025-0148_ref_003","doi-asserted-by":"crossref","unstructured":"Singh, G, Baweja, PS. Creatine Kinase\u2013MB. Am J Clin Pathol 2014;141:415\u20139. https:\/\/doi.org\/10.1309\/ajcpbik3g4bwejko.","DOI":"10.1309\/AJCPBIK3G4BWEJKO"},{"key":"2026051310150656709_j_almed-2025-0148_ref_004","doi-asserted-by":"crossref","unstructured":"Thygesen, K, Alpert, JS, Jaffe, AS, Chaitman, BR, Bax, JJ, Morrow, DA, et al.. Fourth universal definition of myocardial infarction. Circulation 2018;138:e618\u201351.","DOI":"10.1161\/CIR.0000000000000617"},{"key":"2026051310150656709_j_almed-2025-0148_ref_005","doi-asserted-by":"crossref","unstructured":"White, HD. Pathobiology of troponin elevations. J\u00a0Am Coll Cardiol 2011;57:2406\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2011.01.029.","DOI":"10.1016\/j.jacc.2011.01.029"},{"key":"2026051310150656709_j_almed-2025-0148_ref_006","doi-asserted-by":"crossref","unstructured":"Jeremias, A, Gibson, CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005;142:786. https:\/\/doi.org\/10.7326\/0003-4819-142-9-200505030-00015.","DOI":"10.7326\/0003-4819-142-9-200505030-00015"},{"key":"2026051310150656709_j_almed-2025-0148_ref_007","doi-asserted-by":"crossref","unstructured":"Giannitsis, E, Mueller, C, Katus, HA. Skeletal myopathies as a non-cardiac cause of elevations of cardiac troponin concentrations. Diagnosis 2019;6:189\u2013201. https:\/\/doi.org\/10.1515\/dx-2019-0045.","DOI":"10.1515\/dx-2019-0045"},{"key":"2026051310150656709_j_almed-2025-0148_ref_008","doi-asserted-by":"crossref","unstructured":"Hammarsten, O, Warner, JV, Lam, L, Kavsak, P, Lindahl, B, Aakre, KM, et al.. Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC committee on clinical applications of cardiac biomarkers. Clin Chem Lab Med CCLM 2023;61:1411\u20139. https:\/\/doi.org\/10.1515\/cclm-2023-0028.","DOI":"10.1515\/cclm-2023-0028"},{"key":"2026051310150656709_j_almed-2025-0148_ref_009","doi-asserted-by":"crossref","unstructured":"Makunts, T, Saunders, IM, Cohen, IV, Li, M, Moumedjian, T, Issa, MA, et al.. Myocarditis occurrence with cancer immunotherapy across indications\u00a0in clinical trial and post-marketing data. Sci Rep 2021;11:17324. https:\/\/doi.org\/10.1038\/s41598-021-96467-5.","DOI":"10.1038\/s41598-021-96467-5"},{"key":"2026051310150656709_j_almed-2025-0148_ref_010","doi-asserted-by":"crossref","unstructured":"Pathak, R, Katel, A, Massarelli, E, Villaflor, VM, Sun, V, Salgia, R. Immune checkpoint inhibitor\u2013induced myocarditis with myositis\/myasthenia gravis overlap syndrome: a systematic review of cases. The Oncologist 2021;26:1052\u201361. https:\/\/doi.org\/10.1002\/onco.13931.","DOI":"10.1002\/onco.13931"},{"key":"2026051310150656709_j_almed-2025-0148_ref_011","doi-asserted-by":"crossref","unstructured":"Brancaccio, P, Lippi, G, Maffulli, N. Biochemical markers of muscular damage. Clin Chem Lab Med CCLM 2010;48:757\u201367. https:\/\/doi.org\/10.1515\/cclm.2010.179.","DOI":"10.1515\/CCLM.2010.179"},{"key":"2026051310150656709_j_almed-2025-0148_ref_012","doi-asserted-by":"crossref","unstructured":"Du Fay De Lavallaz, J, Prepoudis, A, Wendebourg, MJ, Kesenheimer, E, Kyburz, D, Daikeler, T, et al.. Skeletal muscle disorders: a noncardiac source of cardiac troponin T. Circulation 2022;145:1764\u201379. https:\/\/doi.org\/10.1161\/circulationaha.121.058489.","DOI":"10.1161\/CIRCULATIONAHA.121.058489"},{"key":"2026051310150656709_j_almed-2025-0148_ref_013","doi-asserted-by":"crossref","unstructured":"Schmid, J, Liesinger, L, Birner-Gruenberger, R, Stojakovic, T, Scharnagl, H, Dieplinger, B, et al.. Elevated cardiac troponin T in patients with skeletal myopathies. J\u00a0Am Coll Cardiol 2018;71:1540\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.070.","DOI":"10.1016\/j.jacc.2018.01.070"}],"container-title":["Advances in Laboratory Medicine \/ Avances en Medicina de Laboratorio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0148\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0148\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:21:21Z","timestamp":1778667681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0148\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,5,12]]}},"alternative-id":["10.1515\/almed-2025-0148"],"URL":"https:\/\/doi.org\/10.1515\/almed-2025-0148","relation":{},"ISSN":["2628-491X"],"issn-type":[{"value":"2628-491X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}